169 related articles for article (PubMed ID: 7772705)
21. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
22. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
Teoh KL; Fida S; Rowley MJ; Mackay IR
Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
[TBL] [Abstract][Full Text] [Related]
23. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
Wyatt RC; Brigatti C; Liberati D; Grace SL; Gillard BT; Long AE; Marzinotto I; Shoemark DK; Chandler KA; Achenbach P; Gillespie KM; Piemonti L; Lampasona V; Williams AJK
Diabet Med; 2018 Jul; 35(7):954-963. PubMed ID: 29577424
[TBL] [Abstract][Full Text] [Related]
24. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry.
Vandewalle CL; Falorni A; Svanholm S; Lernmark A; Pipeleers DG; Gorus FK
J Clin Endocrinol Metab; 1995 Mar; 80(3):846-51. PubMed ID: 7883841
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients.
Medici F; Hawa MI; Giorgini A; Panelo A; Solfelix CM; Leslie RD; Pozzilli P
Diabetes Care; 1999 Sep; 22(9):1458-61. PubMed ID: 10480509
[TBL] [Abstract][Full Text] [Related]
27. Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes.
Hampe CS; Ortqvist E; Persson B; Schranz DB; Lernmark A
Horm Metab Res; 1999 Oct; 31(10):553-7. PubMed ID: 10596964
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
29. Conformation-dependent GAD65 autoantibodies in diabetes.
Luo D; Gilliam LK; Greenbaum C; Bekris L; Hampe CS; Daniels T; Richter W; Marcovina SM; Rolandsson O; Landin-Olsson M; Kockum I; Lernmark A
Diabetologia; 2004 Sep; 47(9):1581-91. PubMed ID: 15365614
[TBL] [Abstract][Full Text] [Related]
30. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
[TBL] [Abstract][Full Text] [Related]
31. Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes.
Cram DS; Faulkner-Jones B; Kun J; Harrison LC
Endocrinology; 1995 Mar; 136(3):1111-9. PubMed ID: 7532577
[TBL] [Abstract][Full Text] [Related]
32. Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition.
Primo ME; Anton EA; Villanueva AL; Poskus E; Ermácora MR
Clin Immunol; 2003 Jul; 108(1):38-45. PubMed ID: 12865069
[TBL] [Abstract][Full Text] [Related]
33. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
[TBL] [Abstract][Full Text] [Related]
34. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
35. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset.
Dotta F; Falorni A; Tiberti C; Dionisi S; Anastasi E; Torresi P; Lernmark A; Di Mario U
J Autoimmun; 1997 Dec; 10(6):585-8. PubMed ID: 9451598
[TBL] [Abstract][Full Text] [Related]
37. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
[TBL] [Abstract][Full Text] [Related]
38. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
[TBL] [Abstract][Full Text] [Related]
39. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
